GWW vs ORMP
WW Grainger Inc (GWW) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported GWW revenue for 2024-12-31 was $17.17B. Net income was $1.99B. Revenue was up 4.2% from 2023-12-31 to 2024-12-31. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the GWW and ORMP stock pages for the full models.
Not investment advice.